Project-002
项目-002
基本信息
- 批准号:10666746
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-24 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcute Lymphocytic LeukemiaAdultAffectAnimalsAntibodiesAntibody ResponseB-LymphocytesBindingCD4 Positive T LymphocytesCMV glycoprotein BCellsCessation of lifeChildChildhoodClinical TrialsComplicationCongenital AbnormalityCytomegalovirusCytomegalovirus VaccinesDataDevelopmentDevelopmental Delay DisordersDiseaseEffector CellFc ReceptorFetal DiseasesFetusHealthHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunocompetentImmunocompromised HostImmunoglobulin GImmunologicsImpairmentIncidenceIndividualInfectionInfusion proceduresKnowledgeLinkLymphocyteMF59MacacaMacaca mulattaMaternal-Fetal TransmissionMediatingMediator of activation proteinModelingNatural Killer CellsNeurologicNeurologic DeficitPassive ImmunityPatientsPhagocytosisPhenotypePopulationPregnancyPreventionPrevention strategyPrimary InfectionReceptor CellResearchRhesusRiskRoleSamplingSeizuresSpecificityT-Lymphocyte SubsetsTestingTransplant RecipientsUniversitiesVaccine DesignVaccinesVertical Disease TransmissionViral Load resultVirionVirusVirus DiseasesVirus LatencyWorkantibody-dependent cellular phagocytosisantigen bindingcancer typecareer developmentcell typecohortcongenital cytomegaloviruscytotoxicityexpectationfetalhearing impairmentimprovedmacrophagemonocyteneutralizing antibodynonhuman primatepre-doctoralpregnantpreventprogramspublic health relevancereceptor bindingresponsetransmission processtreatment groupvaccine developmentvaccine trial
项目摘要
ABSTRACT:
Congenital cytomegalovirus (cCMV) infection is the most common placentally transmitted infection worldwide, causing long-lasting complications for affected children, including hearing loss, developmental delays, seizures, and even death. After 40+ years of research, there is no licensed vaccine against CMV, despite high prioritization in vaccine development. Little is currently known about the maternal immune responses that prevent transmission during pregnancy, which is vital information for developing effective vaccines and treatments for cCMV. Prior studies using our rhesus monkey model of placental CMV transmission have determined that the presence of pre-existing antibodies reduce peak maternal viral load and protect against placental transmission, yet the antibody functions that mediated this protection has not been defined. Moreover, our group has demonstrated that non-neutralizing antibody effector functions mediated the partial protection against CMV acquisition achieved in three CMV glycoprotein B vaccine trials. Thus, this study will assess antibody effector functions, including antibody dependent cellular phagocytosis (ADCP) and cytotoxicity (ADCC), as correlates of protection against in utero transmission of CMV in animals with and without pre-existing passive humoral immunity. Binding mediators of antibody effector functions, including Fc receptor binding and cell-associated antigen binding, will also be assessed. Additionally, we will characterize the maternal effector cell populations that mediate non-neutralizing effector functions to explore the role of these cell types in vertical CMV transmission. Considering the high global incidence of cCMV and associated neurologic impairment, developing an effective vaccine guided by established immune correlates to prevent cCMV is imperative to improving global pediatric health.
抽象的:
先天性巨细胞病毒(CCMV)感染是全球最常见的胎盘传播感染,导致受影响儿童的持久并发症,包括听力损失,发育延迟,癫痫发作甚至死亡。经过40多年的研究,尽管疫苗开发方面的优先次序很高,但没有针对CMV的许可疫苗。目前,关于预防怀孕期间传播的母体免疫反应的了解知之甚少,这是开发有效的疫苗和CCMV处理的重要信息。先前使用我们的恒河猴胎盘CMV传播模型的研究确定,现有抗体的存在减少了母体病毒载量并防止胎盘传播,但是介导这种保护的抗体功能尚未定义。此外,我们的小组已经证明,非中和抗体效应子功能介导了针对三项CMV糖蛋白B疫苗试验中获得的CMV采集的部分保护。因此,这项研究将评估抗体效应功能,包括依赖性的细胞吞噬作用(ADCP)和细胞毒性(ADCC),因为在具有和没有预先存在的被动性体体免疫力的动物中,针对子宫内CMV的保护措施相关。还将评估抗体效应功能的结合介质,包括FC受体结合和与细胞相关的抗原结合。此外,我们将表征介导非中和效应子功能的母体效应细胞群,以探索这些细胞类型在垂直CMV传播中的作用。考虑到CCMV的全球发病率和相关的神经系统障碍的高发病率,开发了一种有效的疫苗,以确定的免疫相关性以防止CCMV,这对于改善全球儿科健康至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sallie R. Permar其他文献
Sallie R. Permar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sallie R. Permar', 18)}}的其他基金
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
原发性母体感染后预防先天性巨细胞病毒传播的免疫相关性的识别和建模
- 批准号:
10677439 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
母体血浆广泛中和抗体的逃逸是艾滋病毒母婴传播的机制
- 批准号:
10327003 - 财政年份:2021
- 资助金额:
$ 1.41万 - 项目类别:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
SARS-CoV-2 稳定预灌注 Spike 蛋白疫苗在幼年恒河猴中的免疫原性和功效
- 批准号:
10223633 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别:
相似国自然基金
RBMX通过m6A依赖性相分离调控急性T淋巴细胞白血病发生发展的作用及机制研究
- 批准号:82300189
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
解析急性淋巴细胞白血病染色质可及性异常导致其糖皮质激素耐药的底层分子机制
- 批准号:82270155
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
基因工程敲减IL-6/CD40L的CAR-T细胞在复发/难治性急性B淋巴细胞白血病治疗中提高安全性的机制研究
- 批准号:82200249
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
解析急性淋巴细胞白血病染色质可及性异常导致其糖皮质激素耐药的底层分子机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基因工程敲减IL-6/CD40L的CAR-T细胞在复发/难治性急性B淋巴细胞白血病治疗中提高安全性的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens
Tsepamo Plus:通过模拟临床试验扩大先天性异常监测,以评估体重对新 ART 治疗方案出生结果的影响
- 批准号:
10495244 - 财政年份:2021
- 资助金额:
$ 1.41万 - 项目类别:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
结核病对 SIV 感染婴儿免疫系统发育和功能的影响
- 批准号:
10444441 - 财政年份:2021
- 资助金额:
$ 1.41万 - 项目类别:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
结核病对 SIV 感染婴儿免疫系统发育和功能的影响
- 批准号:
10380637 - 财政年份:2019
- 资助金额:
$ 1.41万 - 项目类别:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
结核病对 SIV 感染婴儿免疫系统发育和功能的影响
- 批准号:
9902482 - 财政年份:2019
- 资助金额:
$ 1.41万 - 项目类别:
Nonmyeloablative Hematopoietic Cell Allotransplants
非清髓性造血细胞同种异体移植
- 批准号:
8277817 - 财政年份:2011
- 资助金额:
$ 1.41万 - 项目类别: